IDiyas

For the Inventor, By the Inventor

Wuppertal, Germany

Klaus G Stunkel

USPTO Granted Patents = 9

Average Co-Inventor Count = 5.0

ph-index = 4

Forward Citations = 74(Granted Patents)


Company Filing History:

goldMedal9 out of 12,157 
 
Bayer Aktiengesellschaft
 patents

Years Active: 1986-1996

Loading Chart...
9 patents (USPTO):Explore Patents
1. 5510365 - Medicaments containing 1-thiocarbamoyl-5-hydroxy-pyrazoles and their use (1996-04-23),
2. 5070190 - Substituted N-glycosylamides, process for their preparation, and their (1991-12-03),
3. 4855283 - Novel pharmaceutically active (1989-08-08),
4. 4737521 - Suramin sodium for use as an immunostimulant (1988-04-12),
5. 4737488 - Immune system-stimulating N-glycosylated ureas and carbamates (1988-04-12),
6. 4716152 - Pharmaceutical use of substituted O-acylglycosides (1987-12-29),
7. 4699899 - Substituted O-sulphonyl-glycosylamides, processes for their preparation (1987-10-13),
8. 4659603 - Immunostimulating agents (1987-04-21),
9. 4574122 - Substituted O-acylglycosylamides, pharmaceutical compositions and method (1986-03-04),

Title: Innovations and Contributions of Klaus G. Stunkel

Introduction

Klaus G. Stunkel is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of medicaments. With a total of nine patents to his name, Stunkel's work has had a considerable impact on medical science.

Latest Patents

Stunkel's latest patents include innovative formulations aimed at addressing critical health issues. One of his notable inventions is related to medicaments containing 1-thiocarbamoyl-5-hydroxy-pyrazoles. This invention focuses on the use of these compounds as pharmaceutical agents for combating septic shock and its consequences. Another significant patent involves substituted N-glycosylamides, which are new compounds that can be synthesized for various applications in medicine.

Career Highlights

Throughout his career, Klaus G. Stunkel has been associated with Bayer Aktiengesellschaft, a leading global pharmaceutical company. His work at Bayer has allowed him to collaborate with other experts in the field and contribute to groundbreaking research and development.

Collaborations

Stunkel has worked alongside esteemed colleagues such as Oswald Lockhoff and Hans-Joachim Zeiler. Their collaborative efforts have further advanced the research and development of innovative pharmaceutical solutions.

Conclusion

Klaus G. Stunkel's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of new medical treatments and innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…